Risperidone is a widely used antipsychotic, known to cause secondary hyperprolactinaemia. Hyperprolactinaemia is associated with erectile dysfunction, amenorrhea and reduced bone mineral density (BMD).
1. The prevalence of Hyperprolactinaemia (>25 ng/ml) in women and men (> 20 ng/ml) were 84.4% and 78.8%
respectively. 2. Erectile dysfunction was reported by 44% men (n=14) and amenorrhea by 24% women (n=8) 3. Subnormal BMD was found in 50% of the subjects. 4. Furthermore, 30% subjects had vitamin D deficiency (<20 ng/ml) and 61% had vitamin D insufficiency (<30 ng/ml). 5. Significant association was observed between subjects having either ED or MD with subnormal BMD as compared to those not having them (OR 3.71; 95% CI: 1.23-11.24.P=0.02). 
